Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT
Status:
Terminated
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether an alpha-glucosidase inhibitor, a drug for
the suppression of postprandial hyperglycemia, could reduce the recurrence of myocardial
infarction in patients with impaired glucose tolerance (IGT) and old myocardial infarction.